Clinical Trial Update: Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 single-arm neoadjuvant trial evaluating Paclitaxel Polymersomes with Carboplatin and Adebelimab in patients with resectable mucosal melanoma; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucosal Melanoma

Drugs mentioned

• Adebelimab (adebelimab)
• CARBOPLATIN (Carboplatin)
• Paclitaxel Polymersomes (paclitaxel polymersomes)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Resectable Mucosal Melanoma | Phase 2 | Status: RECRUITING